Asset Details
Do you wish to reserve the book?
Assessing AI-augmented training for multiple sclerosis classification in a basal ganglia radiomics model
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Assessing AI-augmented training for multiple sclerosis classification in a basal ganglia radiomics model
Do you wish to request the book?
Assessing AI-augmented training for multiple sclerosis classification in a basal ganglia radiomics model
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Assessing AI-augmented training for multiple sclerosis classification in a basal ganglia radiomics model
2025
Overview
Multiple sclerosis (MS) radiomics is hindered by multicenter variability and limited sample sizes. We evaluated whether GAN-based augmentation (GBA) improves MS classification versus traditional data augmentation (TDA) under center-wise external testing. A conditional GAN generated T1-weighted brain MRIs conditioned on class labels. Ten subcortical regions (including thalamus, putamen, caudate) were segmented with a 3D U-Net; radiomic features (shape, first-order, and texture families) were extracted and selected with LASSO. We used a leave-one-center-out (LOCO) design. All model development, segmentation, cGAN training, feature engineering, and tuning, were performed within the training centers only using inner 5-fold (subject-level 80/20) splits; the entire held-out center was reserved for a single external test. Across centers, GBA yielded small but consistent gains over TDA and real-only training, most evident for a tabular ResNet (average F1 up to 0.957), while confidence intervals overlapped for some metrics. SHAP analyses preserved the salience of basal-ganglia features, supporting biological plausibility. Limitations include a single-country cohort and no public external validation, which constrains generalizability. AI-augmented training provides incremental improvements for MS radiomics under site-held-out testing and motivates broader, international validation and clinically oriented utility analyses.
Publisher
BioMed Central,BioMed Central Ltd,BMC
